Difference between revisions of "B-cell CLL/lymphoma 2"
Jump to navigation
Jump to search
| Line 9: | Line 9: | ||
*[[Reactive follicular hyperplasia]]. | *[[Reactive follicular hyperplasia]]. | ||
*[[Immunohistochemistry]]. | *[[Immunohistochemistry]]. | ||
*[[BCL6]]. | |||
==References== | ==References== | ||
Latest revision as of 15:50, 26 April 2022
B-cell CLL/lymphoma 2, officially it is abbreviated BCL2,[1] in an oncogene that was described in the context of CLL. It is expressed in other small cell lymphomas.
Commonly used abbreviations include bcl-2 and BCL-2.